Diagnosis and management of Specific Antibody Deficiency
- PMID: 32654695
- DOI: 10.1016/j.iac.2020.03.005
Diagnosis and management of Specific Antibody Deficiency
Abstract
Specific antibody deficiency is a primary immunodeficiency disease recognized by the International Union of Immunology Societies and defined by recurrent respiratory infections with normal immunoglobulins, but diminished antibody responses to polysaccharide antigens after vaccination with the 23 valent pneumococcal polysaccharide vaccine. Clinical immunologists struggle with diagnosis and treatment, because the definition of an adequate response to immunization remains controversial. Specific antibody deficiency is managed clinically with close follow-up and prompt treatment of infections, antibiotic prophylaxis, or immune globulin therapy. Treatment is individualized using clinical judgment and existing practice guidelines, which will likely evolve as more studies become available.
Keywords: Antibody deficiency; Diagnosis; Immunoglobulin replacement therapy; PCV13; PPSV23; Pneumococcal vaccines; Primary immunodeficiency; Specific antibody deficiency.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure E.E. Perez: Consultancy and speaker bureau for CSL Behring, Takeda, Genentech; recent clinical trial PI or co-PI with Octapharma, Kedrion, Green Cross; M. Barrow: Physician advisory board and speaker bureau for CSL Behring, Takeda and Grifols; consulting medical director for the Immune Deficiency Foundation; Data Safety Monitoring Board – Prometic, Glenmark.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources